FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35084311000001107: Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1799461000001116 Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1799471000001114 Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Is a Teduglutide 1.25mg powder and solvent for solution for injection vials true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has active ingredient Teduglutide true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has specific active ingredient Teduglutide true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has dispensed dose form Powder and solvent for solution for injection true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Is a Revestive true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) 28 vial Has AMP True Revestive 1.25mg powder and solvent for solution for injection vials (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start